New Key Statistics Module, Z-Score and F-Score
OTCPK:CASBF Key Ratios
| Market Cap $ M | 1,413.43 |
| Enterprise Value $ M | 1,185.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.23 |
| Price/Sales | 10.14 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 84.00 |
| EPS (TTM) $ | -0.49 |
| Beneish M-Score | -16.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.64 |
| EV-to-EBITDA | -9.64 |
| PEG | -- |
| Shares Outstanding M | 247.45 |
| Net Margin (%) | -142.92 |
| Operating Margin % | -145.64 |
| Pre-tax Margin (%) | -152.45 |
| Quick Ratio | 2.19 |
| Current Ratio | 2.38 |
| ROA % (ttm) | -9.54 |
| ROE % (ttm) | -16.02 |
| ROIC % (ttm) | -15.92 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.70 |
CASBF Number of Guru Trades
CASBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CASBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CASBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CanSino Biologics Inc Insider Transactions
No Available Data
News about OTCPK:CASBF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers